J Int Neuropsychol Soc 10:412426 Wechsler B, Kim H, Gallagher PR, DiScala C, Stineman MG (2005) Functional status after childhood traumatic brain injury
While peptide-based GLP-1R agonists such as semaglutide have transformed the treatment landscape, dual incretin receptor engagement further enhances metabolic outcomes
The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma
This article provides an overview of BPC 157, including its origins, potential uses, areas of ongoing research, possible side effects, general dosing considerations, and how it compares to other peptides
doi: 10.1146/annurev-immunol-041015-055605 94 CrottyS
doi: 10.1073/pnas.2300965120 62 XiaoB.TanE.-K